BXP.L

Beximco Pharmaceuticals Limited [BXP.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BXP.L Stock Summary

Top BXP.L Correlated Resources

BXP.L


Top 10 Correlated ETFs

BXP.L


Top 10 Correlated Stocks

BXP.L


BXP.L Financial details

Company Rating
Buy
Market Cap
22.08B
Income
4.26B
Revenue
27.25B
Book val./share
94.25
Cash/share
1.96
Dividend
3.46
Dividend %
6.72%
Employees
5.5K
Optionable
No
Shortable
Yes
Earnings
-
P/E
468.18
Forward P/E
-
PEG
-277.29
P/S
0.01
P/B
0.01
P/C
28.32
P/FCF
0.24
Quick Ratio
0.07
Current Ratio
1.59
Debt / Equity
0.08
LT Debt / Equity
0.07
-
-
EPS (TTM)
9.55
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-23.88%
SMA50
-29.17%
SMA100
-29.17%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
14%
ROC
0.1%
Gross Margin
46%
Oper. Margin
21%
Profit Margin
16%
Payout
36%
Shs Outstand
446.11M
Shs Float
427.96M
-
-
-
-
Target Price
-
52W Range
44.75-131.0
52W High
-57.63%
52W Low
+26.14%
RSI
28
Rel Volume
0.77
Avg Volume
116.8K
Volume
90K
Perf Week
5.71%
Perf Month
-17.16%
Perf Quarter
-24.49%
Perf Half Y
-31.9%
-
-
-
-
Beta
0.840704
-
-
Volatility
2.27%, 6.85%
Prev Close
7.77%
Price
55.5
Change
7.77%

BXP.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-06-30

Metric History 2018-06-302019-06-302020-06-302021-06-30 2022-06-30
Revenue per share
39.6951.1557.4466.090
Net income per share
5.686.87.8811.490
Operating cash flow per share
4.070000
Free cash flow per share
-7.26-3.557.337.760
Cash per share
1.642.091.421.512.62
Book value per share
60.6666.3272.8782.980
Tangible book value per share
57.1762.7369.4679.41-59.94
Share holders equity per share
60.6666.3272.8782.980
Interest debt per share
26.2632.4425.7619.0219.98
Market cap
193.79M170.33M196.61M363.71M357.01M
Enterprise value
10.99B13.04B10.07B7.32B8.1B
P/E ratio
0.080.060.060.070
Price to sales ratio
0.010.010.010.010
POCF ratio
0.110000
PFCF ratio
-0.06-0.110.060.10
P/B Ratio
0.010.010.010.010
PTB ratio
0.010.010.010.010
EV to sales
0.620.570.390.250
Enterprise value over EBITDA
2.312.561.741.020
EV to operating cash flow
6.040000
EV to free cash flow
-3.39-8.233.082.110
Earnings yield
13.0917.8117.8814.10
Free cash flow yield
-16.71-9.3116.629.530
Debt to equity
0.150.090.050.030
Debt to assets
0.370.390.350.280
Net debt to EBITDA
2.272.531.70.970
Current ratio
1.261.041.151.470
Interest coverage
7.24.975.617.370
Income quality
0.720000
Dividend Yield
2.592.973.061.590
Payout ratio
0.20.170.170.110
Sales general and administrative to revenue
0.010.010.010.030
Research and developement to revenue
000.0100
Intangibles to total assets
0.040.040.040.040
Capex to operating cash flow
-2.780000
Capex to revenue
-0.29-0.2-0.09-0.090
Capex to depreciation
-5.98-27.37-11.7400
Stock based compensation to revenue
00000
Graham number
88.06100.73113.68146.460
ROIC
0.110.130.140.150
Return on tangible assets
0.060.060.070.10
Graham Net
-28.66-33.83-29.88-23.09-45.59
Working capital
2.33B518.33M1.69B4.42B0
Tangible asset value
25.52B27.98B30.98B35.44B0
Net current asset value
-5.04B-6.09B-4.27B-1.11B-3.09B
Invested capital
0.410.460.320.210
Average receivables
00000
Average payables
1.29B1.27B1.27B1.97B2.22B
Average inventory
6.76B7.23B7.26B7.8B0
Days sales outstanding
00000
Days payables outstanding
24.0517.1615.3146.0747.72
Days of inventory on hand
221.49199.02178.88182.960
Receivables turnover
00000
Payables turnover
15.1821.2723.857.927.65
Inventory turnover
1.651.832.041.990
ROE
0.090.10.110.140
Capex per share
-11.33-10.19-5.1-5.730

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q1

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
18.9819.0520.08021.94
Net income per share
3.283.842.4703.24
Operating cash flow per share
00000
Free cash flow per share
2.621.870.2700
Cash per share
1.222.651.322.621.96
Book value per share
86.3186.6589.13094.25
Tangible book value per share
82.8284.1986.66-11.7491.73
Share holders equity per share
86.3186.6589.13094.25
Interest debt per share
25.3725.3427.148.427.62
Market cap
426.04M542.03M441.65M314.51M318.97M
Enterprise value
11.03B10.4B11.68B2.6B11.46B
P/E ratio
0.070.080.100.06
Price to sales ratio
0.050.060.0500.03
POCF ratio
00000
PFCF ratio
0.360.653.620154.69
P/B Ratio
0.010.010.0100.01
PTB ratio
0.010.010.0100.01
EV to sales
1.31.221.301.17
Enterprise value over EBITDA
5.224.166.132.015.14
EV to operating cash flow
00000
EV to free cash flow
9.4512.4495.7305.56K
Earnings yield
3.443.162.504.54
Free cash flow yield
2.741.540.2800.01
Debt to equity
0.110.110.0900.08
Debt to assets
0.330.340.3300.32
Net debt to EBITDA
5.023.945.91.775
Current ratio
1.421.321.4301.59
Interest coverage
12.666.386.4306.79
Income quality
00000
Dividend Yield
0.150.013.4900
Payout ratio
0.0401.400
Sales general and administrative to revenue
0.010.040.0400.03
Research and developement to revenue
00000
Intangibles to total assets
0.030.080.0800.08
Capex to operating cash flow
00000
Capex to revenue
-0.1-0.1-0.020-0.07
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
79.8786.5270.4082.94
ROIC
0.040.030.0300.04
Return on tangible assets
0.030.030.0200.02
Graham Net
-31.7-35.98-34.542.62-32.1
Working capital
4.1B4.17B5.38B07.32B
Tangible asset value
36.95B37.56B38.66B040.92B
Net current asset value
-4.93B-4.89B-3.46B0-1.8B
Invested capital
0.290.290.300.29
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
45.4869.0953.51042.64
Days of inventory on hand
173.05206.3194.740209.31
Receivables turnover
00000
Payables turnover
1.981.31.6802.11
Inventory turnover
0.520.440.4600.43
ROE
0.040.040.0300.03
Capex per share
-1.84-1.89-0.390-1.53

BXP.L Frequently Asked Questions

What is Beximco Pharmaceuticals Limited stock symbol ?

Beximco Pharmaceuticals Limited is a BD stock and trading under the symbol BXP.L

What is Beximco Pharmaceuticals Limited stock quote today ?

Beximco Pharmaceuticals Limited stock price is $55.5 today.

Is Beximco Pharmaceuticals Limited stock public?

Yes, Beximco Pharmaceuticals Limited is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks